DK133051B - Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener - Google Patents

Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener

Info

Publication number
DK133051B
DK133051B DK368074AA DK368074A DK133051B DK 133051 B DK133051 B DK 133051B DK 368074A A DK368074A A DK 368074AA DK 368074 A DK368074 A DK 368074A DK 133051 B DK133051 B DK 133051B
Authority
DK
Denmark
Prior art keywords
ostratriens
8alfa
oxygenated
preparation
analogical procedure
Prior art date
Application number
DK368074AA
Other languages
English (en)
Other versions
DK133051C (da
DK368074A (da
Inventor
K Prezewowsky
H Laurent
H Hofmeister
R Wiechert
F Neumann
Y Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK368074A publication Critical patent/DK368074A/da
Publication of DK133051B publication Critical patent/DK133051B/da
Application granted granted Critical
Publication of DK133051C publication Critical patent/DK133051C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
DK368074A 1973-07-13 1974-07-09 Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener DK133051C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (3)

Publication Number Publication Date
DK368074A DK368074A (da) 1975-03-17
DK133051B true DK133051B (da) 1976-03-15
DK133051C DK133051C (da) 1976-08-16

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK368074A DK133051C (da) 1973-07-13 1974-07-09 Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener

Country Status (18)

Country Link
JP (1) JPS5821639B2 (da)
AT (1) ATA575574A (da)
AU (1) AU477010B2 (da)
CA (1) CA1030951A (da)
CH (2) CH609064A5 (da)
CS (2) CS182260B2 (da)
DD (1) DD114066A5 (da)
DK (1) DK133051C (da)
ES (1) ES428226A1 (da)
FI (1) FI54131C (da)
FR (1) FR2236505B1 (da)
GB (1) GB1479934A (da)
HU (1) HU169791B (da)
IE (1) IE39872B1 (da)
IL (1) IL45259A (da)
NO (1) NO742546L (da)
SE (1) SE7409151L (da)
SU (1) SU626705A3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
CA1030951A (en) 1978-05-09
SU626705A3 (ru) 1978-09-30
IL45259A0 (en) 1974-10-22
JPS5032160A (da) 1975-03-28
DD114066A5 (da) 1975-07-12
AU7112374A (en) 1976-01-15
JPS5821639B2 (ja) 1983-05-02
AU477010B2 (en) 1976-10-14
FR2236505B1 (da) 1977-07-08
IL45259A (en) 1977-10-31
GB1479934A (en) 1977-07-13
CS182300B2 (en) 1978-04-28
CS182260B2 (en) 1978-04-28
HU169791B (en) 1977-01-28
FI54131C (fi) 1978-10-10
IE39872B1 (en) 1979-01-17
IE39872L (en) 1975-01-13
ATA575574A (de) 1978-05-15
CH609064A5 (en) 1979-02-15
DK133051C (da) 1976-08-16
FI54131B (fi) 1978-06-30
NO742546L (da) 1975-02-10
FR2236505A1 (da) 1975-02-07
DK368074A (da) 1975-03-17
ES428226A1 (es) 1976-07-16
FI213974A (da) 1975-01-14
SE7409151L (sv) 1975-01-14
CH614217A5 (en) 1979-11-15

Similar Documents

Publication Publication Date Title
DK138501C (da) Analogifremgangsmaade til fremstilling af 3alfa-hydroxy-d-homo-5alfa-pregnan-11,20-dioner
DK136066C (da) Analogifremgangsmade til fremstilling af 1-substituerede pyrazoloner-(5)
DK133051C (da) Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener
DK132892C (da) Analogifremgangsmade til fremstilling af 4-aminoquinazoliner
DK132707C (da) Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener
DK133050C (da) Analogifremgangsmade til fremstilling af 3,17,18-trihydroxy-1,3,5(10)-ostratriener
DK136729C (da) Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner
DK136155C (da) Analogifremgangsmade til fremstilling af pyrazoloner-(5)
DK136249C (da) Analogifremgangsmade til fremstilling af xanthenderivater
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
DK133011C (da) Analogifremgangsmade til fremstilling af 4'-dehydro-oleandrin
DK136183B (da) Fremgangsmade til fremstilling af 1-chlor-2,2,2-trifluorethyl-difluormethylether
DK133303C (da) Analogifremgangsmade til fremstilling af digitoxinorthoformiater
DK138500C (da) Analogifremgangsmaade til fremstilling af 6alfa-fluor-21-hydroxy-16alfa-methyl-1,4,8-pregnatrien-3,20-dioner
DK134817C (da) Analogifremgangsmade til fremstilling af 3beta-(4'-oxo-alfa-l-rhamnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid
DK131859C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK134756C (da) Analogifremgangsmade til fremstilling af 1-alkyl-2-(pyridylthiomethyl)-5-nitro-imidazoler savel som 1-alkyl-2-(n-oxypyridylthiomethyl)-5-nitro-imidazoler
DK132439C (da) Analogifremgangsmade til fremstilling af 17-steroidylestratriener
DK312179A (da) Analogifremgangsmaade til fremstilling af 6-desoxy-6-azido-14-hydroxy-7,8-dihydroixomorphin-derivater
DK387477A (da) Analogifremgangsmade til fremstilling af 2-hydroxyethyl-7,8-dimethoxypyrimido(4,5b)-quinolin-4(3h)-on-2-carboxylat
DK578275A (da) Analogifremgangsmade til fremstilling af en 3,4-dihydro-3-phenyl-2h,5h-1-bensothiopyrano-(3,4-2)(1,3)-oxazin-2,4-dion-6,6-dioxid-forbindelse
DK132660C (da) Analogifremgangsmade til fremstilling af 1,5-benzodiazepinderivater
DK135946C (da) Analogifremgangsmade til fremstilling af 2,1,3-benzthiadiazolderivater

Legal Events

Date Code Title Description
PBP Patent lapsed